Search research articles
Contact Us
Filters
Showing results (61-70 of 144) with videos related to
Page
of 15
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
May 3, 2013
Pilot study of prophylactic ex vivo costimulated donor leukocyte infusion after reduced-intensity conditioned allogeneic stem cell transplantation
Anita J Kumar, Elizabeth O Hexner, Noelle V Frey, et al.
Blood
|
March 2, 2017
Hsp90 inhibition destabilizes Ezh2 protein in alloreactive T cells and reduces graft-versus-host disease in mice
Qingrong Huang, Shan He, Yuanyuan Tian, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
July 13, 2014
Early donor chimerism levels predict relapse and survival after allogeneic stem cell transplantation with reduced-intensity conditioning
Ran Reshef, Elizabeth O Hexner, Alison W Loren, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 1, 2023
Axicabtagene Ciloleucel in Combination with the 4-1BB Agonist Utomilumab in Patients with Relapsed/Refractory Large B-Cell Lymphoma: Phase 1 Results from ZUMA-11
Michael D Jain, David B Miklos, Caron A Jacobson, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
October 14, 2018
Extended CCR5 Blockade for Graft-versus-Host Disease Prophylaxis Improves Outcomes of Reduced-Intensity Unrelated Donor Hematopoietic Cell Transplantation: A Phase II Clinical Trial
Ran Reshef, Alex Ganetsky, Edward P Acosta, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
December 30, 2015
The Notch Ligand DLL4 Defines a Capability of Human Dendritic Cells in Regulating Th1 and Th17 Differentiation
Lijun Meng, Zhenjiang Bai, Shan He, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 1, 2026
CAR T-Cell Therapy for Cancer: Updates and Challenges for Response Assessment
Dorine de Jong, Jeremy P McGale, Timothy J Robinson, et al.
The Lancet. Oncology
|
February 3, 2024
Tabelecleucel for allogeneic haematopoietic stem-cell or solid organ transplant recipients with Epstein-Barr virus-positive post-transplant lymphoproliferative disease after failure of rituximab or rituximab and chemotherapy (ALLELE): a phase 3, multicentre, open-label trial
Kris Michael Mahadeo, Robert Baiocchi, Amer Beitinjaneh, et al.
The New England Journal of Medicine
|
July 13, 2012
Blockade of lymphocyte chemotaxis in visceral graft-versus-host disease
Ran Reshef, Selina M Luger, Elizabeth O Hexner, et al.
Nature Communications
|
December 31, 2024
PSCA-targeted BPX-601 CAR T cells with pharmacological activation by rimiducid in metastatic pancreatic and prostate cancer: a phase 1 dose escalation trial
Mark N Stein, Ecaterina E Dumbrava, Benjamin A Teply, et al.
Page
of 15
Search research articles
Search
Showing results (61-70 of 144) with videos related to
Sort By:
Page
of 15
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
May 3, 2013
Pilot study of prophylactic ex vivo costimulated donor leukocyte infusion after reduced-intensity conditioned allogeneic stem cell transplantation
Anita J Kumar, Elizabeth O Hexner, Noelle V Frey, et al.
Blood
|
March 2, 2017
Hsp90 inhibition destabilizes Ezh2 protein in alloreactive T cells and reduces graft-versus-host disease in mice
Qingrong Huang, Shan He, Yuanyuan Tian, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
July 13, 2014
Early donor chimerism levels predict relapse and survival after allogeneic stem cell transplantation with reduced-intensity conditioning
Ran Reshef, Elizabeth O Hexner, Alison W Loren, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 1, 2023
Axicabtagene Ciloleucel in Combination with the 4-1BB Agonist Utomilumab in Patients with Relapsed/Refractory Large B-Cell Lymphoma: Phase 1 Results from ZUMA-11
Michael D Jain, David B Miklos, Caron A Jacobson, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
October 14, 2018
Extended CCR5 Blockade for Graft-versus-Host Disease Prophylaxis Improves Outcomes of Reduced-Intensity Unrelated Donor Hematopoietic Cell Transplantation: A Phase II Clinical Trial
Ran Reshef, Alex Ganetsky, Edward P Acosta, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
December 30, 2015
The Notch Ligand DLL4 Defines a Capability of Human Dendritic Cells in Regulating Th1 and Th17 Differentiation
Lijun Meng, Zhenjiang Bai, Shan He, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 1, 2026
CAR T-Cell Therapy for Cancer: Updates and Challenges for Response Assessment
Dorine de Jong, Jeremy P McGale, Timothy J Robinson, et al.
The Lancet. Oncology
|
February 3, 2024
Tabelecleucel for allogeneic haematopoietic stem-cell or solid organ transplant recipients with Epstein-Barr virus-positive post-transplant lymphoproliferative disease after failure of rituximab or rituximab and chemotherapy (ALLELE): a phase 3, multicentre, open-label trial
Kris Michael Mahadeo, Robert Baiocchi, Amer Beitinjaneh, et al.
The New England Journal of Medicine
|
July 13, 2012
Blockade of lymphocyte chemotaxis in visceral graft-versus-host disease
Ran Reshef, Selina M Luger, Elizabeth O Hexner, et al.
Nature Communications
|
December 31, 2024
PSCA-targeted BPX-601 CAR T cells with pharmacological activation by rimiducid in metastatic pancreatic and prostate cancer: a phase 1 dose escalation trial
Mark N Stein, Ecaterina E Dumbrava, Benjamin A Teply, et al.
Page
of 15